SCHEMBL30740808

SCHEMBL30740808

COC(=O)c1ccnc(CO)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 3/20 0.57
KDM4E B2RXH2 2/20 0.57
KDM5C P41229 2/20 0.57
KDM6B O15054 1/20 0.57
KDM2A Q9Y2K7 1/20 0.57
KDM3A Q9Y4C1 1/20 0.57
ALOX15 P16050 2/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
JMJD6 Q6NYC1 1/20 0.50
NPC1 O15118 1/20 0.49
HPGD P15428 1/20 0.49
RAB9A P51151 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
KDM5B Q9UGL1 4/20 0.47
KDM5A P29375 3/20 0.47
HTT P42858 1/20 0.46
CYP4F2 P78329 2/20 0.45
CYP4A11 Q02928 2/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL348975 1.00 KDM4C (0.57) KDM4CKDM4EKDM5CKDM6BKDM2A
SCHEMBL10263738 0.86 KDM4E (0.57) KDM4CKDM4EKDM5CKDM6BKDM2A
SCHEMBL31320065 0.86 KDM4E (0.57) KDM4CKDM4EKDM5CKDM6BKDM2A
SCHEMBL29700409 0.85 KDM4E (0.55) KDM4CKDM4EKDM5CKDM6BKDM2A
SCHEMBL22005801 0.85 KDM5C (0.55) KDM4CKDM4EKDM5CKDM6BKDM2A
SCHEMBL4450004 0.85 KDM4E (0.55) KDM4CKDM4EKDM5CKDM6BKDM2A
SCHEMBL1007105 0.85 KDM4E (0.55) KDM4CKDM4EKDM5CKDM6BKDM2A
SCHEMBL16215925 0.85 KDM4C (0.55) KDM4CKDM4EKDM5CKDM6BKDM2A
SCHEMBL30378291 0.85 KDM4C (0.55) KDM4CKDM4EKDM5CKDM6BKDM2A
SCHEMBL1287072 0.85 KDM4C (0.55) KDM4CKDM4EKDM5CKDM6BKDM2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4702025-A1 BICYCLIC HETEROCYCLE COMPOUNDS FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2026-03-04 EP disclosed
WO-2024223715-A1 BICYCLIC HETEROCYCLE COMPOUNDS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2024-10-31 WO disclosed
CN-117043154-A GPCR receptor agonists, pharmaceutical compositions comprising same, and methods of use thereof 卡莫特医疗有限公司 2023-11-10 CN disclosed